| Cash Flow | 2025-06-30 |
|---|---|
| Net loss | -2,065,825 |
| Preferred shares issued with debt | 401 |
| Prepaid expenses | 105,179 |
| Other asset | 0 |
| Inventory | 95,573 |
| Accounts receivable | 14,071 |
| Accounts payable and accrued liabilities | 1,573,277 |
| Change in fair value of derivative liability | -1,477 |
| Depreciation and amortization expense | 106,646 |
| Amortization of debt discount | 57,864 |
| Cash provided (used) by operating activities | -540,984 |
| Purchase of property and equipment | 110,582 |
| Cash used by investing activities | -110,582 |
| Proceeds from issuance of debt | 1,100,000 |
| Cash provided by financing activities | 1,100,000 |
| Net increase in cash | 448,434 |
Regenerative Medical Technology Group Inc. (RMTG)
Regenerative Medical Technology Group Inc. (RMTG)